These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 11888585)

  • 41. Contraception-related deep venous thrombosis and pulmonary embolism in a 17-Year-old girl heterozygous for factor V leiden, prothrombin G20210A mutation, MTHFR C677T and homozygous for PAI-1 mutation: report of a family with multiple genetic risk factors and review of the literature.
    Lenicek Krleza J; Jakovljevic G; Bronic A; Coen Herak D; Bonevski A; Stepan-Giljevic J; Roic G
    Pathophysiol Haemost Thromb; 2010; 37(1):24-9. PubMed ID: 20664190
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Deletion polymorphism in the angiotensin-converting enzyme gene as a thrombophilic risk factor after hip arthroplasty.
    Philipp CS; Dilley A; Saidi P; Evatt B; Austin H; Zawadsky J; Harwood D; Ellingsen D; Barnhart E; Phillips DJ; Hooper WC
    Thromb Haemost; 1998 Dec; 80(6):869-73. PubMed ID: 9869151
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mild hyperhomocysteinemia and MTHFR C677T do not increase the risk for venous thrombosis in a Spanish population.
    Vargas M; Soto I; Pinto CR; Urgelles MF; Coto E
    Blood Coagul Fibrinolysis; 1998 Sep; 9(6):555-6. PubMed ID: 9819008
    [No Abstract]   [Full Text] [Related]  

  • 44. Methylenetetrahydrofolate reductase gene C677T mutation and plasma homocysteine level in Behçet's disease.
    Canataroglu A; Tanriverdi K; Inal T; Seydaoglu G; Arslan D; Ozbek S; Baslamisli F
    Rheumatol Int; 2003 Sep; 23(5):236-40. PubMed ID: 14504916
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Methylenetetrahydrofolate reductase polymorphism (C677T), hyperhomocysteinemia, and risk of ischemic cardiovascular disease and venous thromboembolism: prospective and case-control studies from the Copenhagen City Heart Study.
    Frederiksen J; Juul K; Grande P; Jensen GB; Schroeder TV; Tybjaerg-Hansen A; Nordestgaard BG
    Blood; 2004 Nov; 104(10):3046-51. PubMed ID: 15226189
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Correlations between methylenetetrahydrofolate reductase gene polymorphisms and venous thromboembolism: A meta-analysis of 99 genetic association studies.
    Zeng J; Zeng Q
    Eur J Prev Cardiol; 2019 Jan; 26(2):120-134. PubMed ID: 30466296
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Impact of new mutations in the methylenetetrahydrofolate reductase gene assessed on biochemical phenotypes: a familial study.
    Tonetti C; Amiel J; Munnich A; Zittoun J
    J Inherit Metab Dis; 2001 Dec; 24(8):833-42. PubMed ID: 11916316
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical significance of determining plasma homocysteine: case-control study on arterial and venous thrombotic patients.
    Vuckovic BA; Cabarkapa VS; Ilic TA; Salatic IR; Lozanov-Crvenkovic ZS; Mitic GP
    Croat Med J; 2013 Oct; 54(5):480-8. PubMed ID: 24170727
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [A common mutation C677T in the 5,10-methyltetrahydrofolate reductase gene is associated to idiopathic deep venous thrombosis].
    Berrut G; Ghali A; Quere I; Ternisien C; Gallois I; Roy PM; Marre M; Fressinaud P
    Rev Med Interne; 2003 Sep; 24(9):569-76. PubMed ID: 12951177
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Observationally and Genetically High YKL-40 and Risk of Venous Thromboembolism in the General Population: Cohort and Mendelian Randomization Studies.
    Kjaergaard AD; Johansen JS; Bojesen SE; Nordestgaard BG
    Arterioscler Thromb Vasc Biol; 2016 May; 36(5):1030-6. PubMed ID: 26988593
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Is the oral methionine loading test insensitive to the remethylation pathway of homocysteine?
    Cattaneo M; Lombardi R; Lecchi A; Zighetti ML
    Blood; 1999 Feb; 93(3):1118-20. PubMed ID: 10025987
    [No Abstract]   [Full Text] [Related]  

  • 52. Measurement of red blood cell methylfolate.
    Lucock M; Yates Z
    Lancet; 2002 Sep; 360(9338):1021-2; author reply 1022. PubMed ID: 12383688
    [No Abstract]   [Full Text] [Related]  

  • 53. Factor V Leiden and the risk for venous thromboembolism in the adult Danish population.
    Juul K; Tybjaerg-Hansen A; Schnohr P; Nordestgaard BG
    Ann Intern Med; 2004 Mar; 140(5):330-7. PubMed ID: 14996674
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The VITA project: C677T mutation in the methylene-tetrahydrofolate reductase gene and risk of venous thromboembolism.
    Tosetto A; Missiaglia E; Frezzato M; Rodeghiero F
    Br J Haematol; 1997 Jun; 97(4):804-6. PubMed ID: 9217179
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Recurrent cerebral venous thrombosis associated with heterozygote methylenetetrahydrofolate reductase C677T mutation and sickle cell trait without homocysteinemia: an autopsy case report and review of literature.
    Ali Z; Troncoso JC; Fowler DR
    Forensic Sci Int; 2014 Sep; 242():e52-e55. PubMed ID: 25074331
    [TBL] [Abstract][Full Text] [Related]  

  • 56. High concentrations of soluble P-selectin are associated with risk of venous thromboembolism and the P-selectin Thr715 variant.
    Ay C; Jungbauer LV; Sailer T; Tengler T; Koder S; Kaider A; Panzer S; Quehenberger P; Pabinger I; Mannhalter C
    Clin Chem; 2007 Jul; 53(7):1235-43. PubMed ID: 17510305
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A retrospective examination of adjunctive L-methylfolate in children and adolescents with unipolar depression.
    Bopp EA; Poweleit EA; Cox MO; Farrow JE; Strawn JR; Patino Duran LR; Prows CA; DelBello MP; Ramsey LB
    J Affect Disord; 2022 Sep; 312():315-321. PubMed ID: 35753502
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The methylfolate axis in neural tube defects: in vitro characterisation and clinical investigation.
    Lucock MD; Wild J; Schorah CJ; Levene MI; Hartley R
    Biochem Med Metab Biol; 1994 Aug; 52(2):101-14. PubMed ID: 7993656
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A pilot study to assess the effect of a three-month vitamin supplementation containing L-methylfolate on systemic homocysteine plasma concentrations and retinal blood flow in patients with diabetes.
    Schmidl D; Howorka K; Szegedi S; Stjepanek K; Puchner S; Bata A; Scheschy U; Aschinger G; Werkmeister RM; Schmetterer L; Garhofer G
    Mol Vis; 2020; 26():326-333. PubMed ID: 32355442
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Increased plasma levels of lipoprotein(a) and the risk of idiopathic and recurrent venous thromboembolism.
    Marcucci R; Liotta AA; Cellai AP; Rogolino A; Gori AM; Giusti B; Poli D; Fedi S; Abbate R; Prisco D
    Am J Med; 2003 Dec; 115(8):601-5. PubMed ID: 14656611
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.